Company & Sponsor Intelligence
Rabin Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed1
Countries1
Therapeutic footprint
adhdanxietyparkinsonsstroke
Indexed studies
NCT04962334Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for Attention Deficit Hyperactivity Disorder (ADHD)
adhd · IsraelNA
adhd · IsraelNA
NCT03696732Anxiety and Phenylephrine Dosage
anxiety · IsraelUNKNOWN
anxiety · IsraelUNKNOWN
NCT01145261The Relationship Between Emotional Regulation Strategies And Cognitive Behavioral Treatment Effectiveness In Childhood Anxiety Disorders: A Longitudinal Prospective Study
anxiety · IsraelCOMPLETED
anxiety · IsraelCOMPLETED
NCT02242084Thrombolysis in Ischemic Spinal Cord Stroke
stroke · IsraelPHASE2
stroke · IsraelPHASE2
NCT01190553Pilot Study of Maintenance Therapy With Intravenous AMANTADINE
parkinsons · NA
parkinsons · NA
NCT02315651Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder
adhd · IsraelNA
adhd · IsraelNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →